Compare EQPT & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EQPT | MMSI |
|---|---|---|
| Founded | 2015 | 1987 |
| Country | United States | United States |
| Employees | 8206 | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.1B |
| IPO Year | N/A | 1996 |
| Metric | EQPT | MMSI |
|---|---|---|
| Price | $19.08 | $70.84 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 8 |
| Target Price | $38.88 | ★ $98.88 |
| AVG Volume (30 Days) | ★ 2.3M | 803.4K |
| Earning Date | 03-18-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.93 |
| EPS | N/A | ★ 0.68 |
| Revenue | N/A | ★ $1,515,906,000.00 |
| Revenue This Year | $21.53 | $8.85 |
| Revenue Next Year | $23.15 | $5.88 |
| P/E Ratio | ★ N/A | $104.47 |
| Revenue Growth | N/A | ★ 11.75 |
| 52 Week Low | $17.95 | $59.74 |
| 52 Week High | $35.50 | $96.74 |
| Indicator | EQPT | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 42.17 | 62.78 |
| Support Level | $18.71 | $66.19 |
| Resistance Level | $26.64 | $71.68 |
| Average True Range (ATR) | 1.71 | 2.12 |
| MACD | -0.33 | 0.32 |
| Stochastic Oscillator | 6.18 | 79.45 |
EquipmentShare.com Inc is a vertically integrated platform that combines proprietary technology, a connected equipment fleet, and a nationwide footprint to serve the construction industry. The company operates its business through the following reportable segments: Equipment Rental and Services Operations, comprised of recurring activity performed at full-service branch locations, such as equipment rentals and related services, and sales of parts, supplies, and maintenance services to construction contractors and others. Equipment Sales, sales of new or used equipment made at any of the branch locations and dealership sites, including equipment sales to participants in the OWN Program.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.